甲戊酸途径
免疫系统
可药性
胆固醇
肿瘤微环境
癌症研究
癌症
癌细胞
细胞生物学
生物
生物化学
免疫学
遗传学
基因
生物合成
作者
Joanna Kopecka,Martina Godel,Chiara Riganti
标识
DOI:10.1016/j.biocel.2020.105876
摘要
Mevalonate pathway is a highly conserved pathway that produces isoprenoids and cholesterol, and it is often increased in cancer cells. Cholesterol, upstream metabolites including isoprenoids and cholesterol derivatives such as oxysterols modulate cell proliferation, motility, stemness and drug resistance. Moreover, when produced by cancer cells or immune infiltrating cells, they modulate the activity of immune populations of the tumor microenvironment. In this review, we will focus on the recent findings demonstrating that cholesterol derivatives may regulate tumor immune recognition or immune escape, playing a critical role in the immune surveillance. Since the mevalonate pathway is druggable, a deeper knowledge of the metabolic cross talks existing between the mevalonate pathway of cancer cells and immune cells may help to identify novel agents targeting cholesterol metabolism, able to boost the anti-tumor activity of the immune populations.
科研通智能强力驱动
Strongly Powered by AbleSci AI